Prostate Cancer
ASTuTE
Shared decision making using multimodal Artificial Intelligence (MMAI) with digital histopathology for Androgen Deprivation Therapy (ADT) use in men with intermediate risk prostate cancer managed with standard of care radiotherapy.
Trial overview
Radiation Oncology
Prostate Cancer
II
Registration number: ACTRN12623000713695
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=385964&isReview=true
Radiation Oncologist
Dr Mario Guerrieri
MBBS, FRANZCR
Cabrini (Gandel Wing) +3
Radiation Oncologist
Professor Jarad Martin
MBChB BSc PhD DMed, FRANZCR GAustMS
Maitland (Oncology) +1
Radiation oncologist
A/Prof Tee Lim
MBBS, FRANZCR
Fiona Stanley Hospital (Oncology) +2
Radiation Oncologist
Dr Jeremy de Leon
BSc (Bioinformatics), M.B.B.S (Honours), FRANZCR
Darlinghurst (Oncology)
Radiation Oncologist
Dr Bradley Wong
MBBS, FRANZCR
Buderim (Oncology) +1
Radiation Oncologist
Dr James MacKean
MBBS, FRANZCR
Wesley Medical Centre (Oncology) +2
Radiation Oncologist
Dr Sagar Ramani
MBBS MRCP (UK) FRCR (UK) FRANZCR
Tugun (Oncology) +1
Radiation Oncologist
Dr Marcus Dreosti
BSc, Hons LLB, MBBS (Hons) FRANZCR
Kurralta Park (Oncology) +2
Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.